Portfolio of Coronavirus Vaccine Stocks

The following table includes 12 coronavirus vaccine stocks.


12 Coronavirus Vaccine Stocks

Returns

Symbol

Recent Prices

AltimmuneALT
AstraZenecaAZN
BioNTechBNTX
GlaxoSmithKlineGSK
Heat BiologicsHTBX
Inovio PharmaceuticalsINO
Johnson & JohnsonJNJ
ModernaMRNA
NovavaxNVAX
PfizerPFE
SanofiSNY
VaxartVXRT
Price charts from Alpha Vantage as of most recent close.


Portfolio Values


To inspect the performance of the Coronavirus Vaccine Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 10 stocks included in the portfolio computations are: ALT, AZN, GSK, HTBX, INO, JNJ, NVAX, PFE, SNY and VXRT. The current value of the portfolio assumes that $1,000.00 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. BNTX and MRNA were excluded from the portfolio computations because of insufficient price data.

The current value of a $10,000 investment is $16,359. The percent return is 63.59%. The annualized return is 27.90%.





See Portfolio of Coronavirus Stocks.

See Portfolio of Coronavirus Lockdown Stocks.

See Portfolio of Coronavirus Treatment and Vaccine Stocks

Related Portfolios

Portfolio of Medical Device Maker Stocks

Portfolio of Medical Diagnostic Stocks

Portfolio of Medical Equipment Stocks

Portfolio of Medical Instruments and Supplies Stocks

Portfolio of Medical Laboratory and Research Stocks

Portfolio of Telemedicine Stocks

Portfolio of Vaccine Stocks